These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24692730)

  • 1. An early-stage, non-hypervascular HCC successfully treated by superselective, bland transarterial embolization using 40-μm microspheres.
    Tanaka T; Maeda S; Nishiofuku H; Masada T; Sato T; Anai H; Sakaguchi H; Kichikawa K
    Anticancer Res; 2014 Apr; 34(4):1947-51. PubMed ID: 24692730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rupture of hepatocellular carcinoma after transcatheter arterial embolization: an unusual case.
    Sakamoto Y; Kita Y; Takayama T; Kawauchi N; Minagawa M; Makuuchi M
    Hepatogastroenterology; 1999; 46(25):453-6. PubMed ID: 10228840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres.
    Osuga K; Hori S; Hiraishi K; Sugiura T; Hata Y; Higashihara H; Maeda N; Tomoda K; Nakamura H
    Cardiovasc Intervent Radiol; 2008; 31(6):1108-16. PubMed ID: 18543028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma.
    Maluccio MA; Covey AM; Porat LB; Schubert J; Brody LA; Sofocleous CT; Getrajdman GI; Jarnagin W; Dematteo R; Blumgart LH; Fong Y; Brown KT
    J Vasc Interv Radiol; 2008 Jun; 19(6):862-9. PubMed ID: 18503900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
    Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate.
    Rand T; Loewe C; Schoder M; Schmook MT; Peck-Radosavljevic M; Kettenbach J; Wolf F; Schneider B; Lammer J
    Cardiovasc Intervent Radiol; 2005; 28(3):313-8. PubMed ID: 15886943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particle embolization of recurrent hepatocellular carcinoma after hepatectomy.
    Covey AM; Maluccio MA; Schubert J; BenPorat L; Brody LA; Sofocleous CT; Getrajdman GI; Fong Y; Brown KT
    Cancer; 2006 May; 106(10):2181-9. PubMed ID: 16596622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial embolization with microspheres in the treatment of monofocal HCC.
    Nicolini A; Fasani P; Manini MA; Martinetti L; Forzenigo LV; Iavarone M; Crespi S; Rossi G; Biondetti P; Colombo M; Sangiovanni A
    Dig Liver Dis; 2009 Feb; 41(2):143-9. PubMed ID: 18436490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
    Hasegawa I; Hirashima N
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.
    Malagari K; Pomoni M; Kelekis A; Pomoni A; Dourakis S; Spyridopoulos T; Moschouris H; Emmanouil E; Rizos S; Kelekis D
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):541-51. PubMed ID: 19937027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of iodized oil within the nonneoplastic liver adjacent to hepatocellular carcinoma via the drainage routes of the tumor after transcatheter arterial embolization.
    Terayama N; Matsui O; Gabata T; Kobayashi S; Sanada J; Ueda K; Kadoya M; Kawamori Y
    Cardiovasc Intervent Radiol; 2001; 24(6):383-7. PubMed ID: 11907744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bland embolization in patients with unresectable hepatocellular carcinoma using precise, tightly size-calibrated, anti-inflammatory microparticles: first clinical experience and one-year follow-up.
    Bonomo G; Pedicini V; Monfardini L; Della Vigna P; Poretti D; Orgera G; Orsi F
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):552-9. PubMed ID: 19957182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of long-term survival with TAE resistant multiple recurrence HCC successfully treated by hepatic resection].
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Hiramatsu N; Hayashi N; Monden M
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1717-21. PubMed ID: 14619502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superselective particle embolization enhances efficacy of radiofrequency ablation: effects of particle size and sequence of action.
    Tanaka T; Isfort P; Braunschweig T; Westphal S; Woitok A; Penzkofer T; Bruners P; Kichikawa K; Schmitz-Rode T; Mahnken AH
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):773-82. PubMed ID: 23070107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness and timing of one shot transarterial infusion and/or transcatheter arterial embolization therapy for recurrence of postoperative hepatocellular carcinoma].
    Katsumata T; Fukai S; Utsunomiya T
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1903-7. PubMed ID: 1652228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A patient with hepatocellular carcinoma and portal vein thrombosis in 1st branch who was treated by transcatheter arterial embolization].
    Yamamoto T; Nagano H; Sakon M; Miyamoto A; Kondo M; Arai I; Morimoto O; Dono K; Umeshita K; Nakamori S; Murakami T; Nakamura H; Monden M
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1718-23. PubMed ID: 11708017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transarterial immuno-embolization therapy in patients with hepatocellular carcinoma].
    Eguchi H; Takeda T; Sakon M; Umeshita K; Ohzato H; Dono K; Gotoh M; Monden T; Monden M
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1665-7. PubMed ID: 9382502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension?
    Golfieri R; Renzulli M; Mosconi C; Forlani L; Giampalma E; Piscaglia F; Trevisani F; Bolondi L;
    J Vasc Interv Radiol; 2013 Apr; 24(4):509-17. PubMed ID: 23428355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated bland-TAE using small microspheres injected via an implantable port-catheter system for liver metastases: an initial experience.
    Tanaka T; Nishiofuku H; Maeda S; Masada T; Anai H; Sakaguchi H; Kichikawa K
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):493-7. PubMed ID: 23839008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.